SEARCH

SEARCH BY CITATION

References

  • Alveriadou, B.R., Moake, J.L., Ruggeri, Z.M., Turner, N.A., Folie, B.J., Phillips, M.D., Schreiber, A.B., Hrinda, M.E. & McIntire, L.V. (1993) Real-time analysis of shear dependent thrombus formation and its blockade by inhibitors on von Willebrand factor binding to platelets. Blood, 81, 12631276.
  • Amitrano, L., Guardascione, M.A., Ames, P.R, Maragaglione, M., Antinolfi, I., Iannaccone, L., Annunziata, M., Ferrara, F., Brancaccio, V. & Balzano, A. (2003) Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease. American Journal of Hematology, 72, 7581.
  • Berndt, M.C., Shen, Y., Dopheide, S.M., Gardiner, E.E. & Andrews, R.K. (2001) The vascular biology of the glycoprotein IB-IX-V complex. Thrombosis and Haemostasis, 86, 178188.
  • Born, G.V.R. & Wehmeier, A. (1979) Inhibition of platelet thrombus formation by chlorpromazine activity to diminish haemodynamically induced hemolysis. Nature, 282, 212213.
  • Born, G.V.R., Bergquist, K.E. & Artors, K.E. (1976) Evidence for inhibition of platelet aggregation in blood by a drug effect on erythrocytes. Nature, 258, 233235.
  • Bull, B.S., Fujimoto, K., Houwen, B., Klee, G., van Hove, L., van Assendelft, O.W., Bunyaratvej, A., Buttarello, M., Davis, B., Koepke, J.A., Lewis, S.M., Machin, S.J., D'Onofrio, G., Rowan, R.M., Tatsumi, N. and ICSH Expert Panel on Cytometry. (2003) International Council for Standardization in Haematology (ICSH) recommendations for ‘‘surrogate reference’’ method for the packed cell volume. Laboratory Hematology, 9, 19.
  • Editorial (1984) The bleeding-time and haematocrit (editorial). Lancet, 1, 997
  • Erhardt, J.A., Pillarisetti, K. & Toomey, J.R. (2003) Potentiation of platelet activation through the stimulation of P2X1 receptors. Journal of Thrombosis and Haemostasis, 1, 26262635.
  • Gachet, C. (2001) ADP receptors of platelets and their inhibition. Thrombosis and Haemostasis, 86, 222232.
  • Goto, S., Tamura, N., Eto, K, Ikeda, Y. & Handa, S. (2002) Functional significance of adenosine 5′ diphosphate receptor (P2Y12) in platelet activation initiated by binding of von Willebrand Factor to platelet GPIbα induced by conditions of high shear rate. Circulation, 105, 25312536.
  • Harrison, P., Robinson, M.S.C., Mackie, I.J., Joseph, J., McDonald, S.J., Liesner, R., Savidge, G.F., Pasi, J. & Machin, S.J. (1999) Performance of the platelet function analyzer PFA-100 in testing abnormalities of primary hemostasis. Blood Coagulation and Fibrinolysis, 10, 2531.
  • Hechler, B., Lenain, N., Marchese, P., Vial, C., Heim, V., Freund, M., Cazenave, J.P., Cattaneo, M., Ruggeri, Z.M., Evans, R. & Gachet, C. (2003) A role for the fast ATP-gated P2X1 cation channel in thrombosis of small arteries in vivo. Journal of Experimental Medicine 198, 661667.
  • Hellem, A.J., Borchgrevink, C.F. & Ames, S.B. (1961) The role of red cells in haemostasis: The relation between haematocrit, bleeding time and platelet adhesiveness. British Journal of Haematology, 7, 4250.
  • Hollopeter, G., Jantzen, H.M., Vincent, D., Li G., England, L., Ramakrishnan, V., Yang, R.B., Nurden, P., Nurden, A., Julius, D. & Conley, P.B. (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature, 409, 202207.
  • Ikeda, Y., Handa, M., Kawano, K., Kamata, T., Murata, M., Araki, Y., Anbo, H., Kawai, Y., Watanabe, K., Itagaki, I., Skai, K. & Ruggeri, Z.M. (1991) The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. Journal of Clinical Investigation, 87, 12341240.
  • Kessler, C.M. (2004) Propensity for hemorrhage and thrombosis in chronic myeloproliferative disorders. Seminars in Hematology, 41, 1014.
  • Kovacsovics, T.J., Bachelot, C., Toker, A., Vlahos, C.J., Duckworth, B., Cantley, L.C. & Hartwig, J.H. (1995) Phosphoinositide 3-kinase inhibition spares actin assembly in activating platelets but reverses platelet aggregation. Journal of Biological Chemistry, 270, 1135811366.
  • Landolfi, R., Marchioli, R., Kutti, J., Gisslinger, H., Tognoni, G., Patrono, C., Barbui, T. and European Collaborators on low-Dose Aspirin in Polycythemia Vera. (2004) Efficacy and safety of low-dose aspirin in polycythemia vera. New England Journal of Medicine, 350, 114124.
  • Lindmark, E., Tenno, T. & Siegbahn, A. (2000) Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression. Arteriosclerosis Thrombosis and Vascular Biology, 20, 23222328.
  • Moake, J.L., Turner, N.A., Stathopoulos, N.A., Nolasco, L. & Hellums, D.J. (1988) Shear induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large and unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood, 71, 13661374.
  • Oury, C., Kuijpers, M.J.E., Toth-Zsamboki, E., Bonnefoy, A., Danloy, S., Vreys, I., Feijge, M.A.H., DeVos, R., Vermylen, J., Heemskerk, J.W.M. & Hoylaerts, M.F. (2003) Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype. Blood, 101, 39693976.
  • Ozaki, Y., Satoh, K., Yamamoto, T., Shirasawa, Y. & Kume, S. (1994) Detection of platelet aggregates with a particle counting method using light scattering. Analytical Biochemistry, 218, 284294.
  • Peerschke, E.I. (1982) Induction of human platelet fibrinogen receptors by epinephrine in the absence of released ADP. Blood, 60, 7177.
  • Reimers, R.C., Sutera, S.P. & Joist, J.H. (1984) Potentiation by RBC of shear-induced platelet aggregation: relative importance of chemical and physical mechanisms. Blood, 64, 12001206.
  • Ruggeri, Z.M. (1993) Mechanism of shear induced platelet adhesion and aggregation. Thrombosis and Haemostasis, 70, 119123.
  • Santos, M.T., Valles, J., Marcus, A.J., Safier, L.B., Broekman, M.J., Islam, N., Ullman, H.L., Eiroa, A.M. & Aznar, J. (1991) Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. Journal of Clinical Investigation, 87, 571580.
  • Schmid-Schonbein, H., Born, G.V.R., Richardson, P.D., Cusack, N., Rieger, H., Forst, R., Rohlin-Winkel, I., Blasberg, P. & Wehmeyer, A. (1981) Rheology of thrombotic processes in flow: the interaction of erythrocytes and thrombocytes subjected to high flow forces. Biorheology, 18, 415444.
  • Shattil, S.J., Ginsberg, M.H. & Brugge, J.S. (1994) Adhesive signaling in platelets. Current Opinion in Cell Biology, 6, 695704.
  • Shenkman, B., Savion, N., Dardik, R., Tamarin, I. & Varon, D. (2000) Testing of platelet deposition on polystyrene surface under flow conditions by the cone and plate(let) analyzer: role of platelet activation, fibrinogen, and von Willebrand factor. Thrombosis Research, 99, 353361.
  • Stormorken, H. (1971) Platelet, thrombosis and hemolysis. Federation Proceedings, 30, 15511556.
  • Toth-Zsamboki, E., Oury, C., Cornelissen, H., DeVos, R., Vermylen, J. & Hoylaerts, M.F. (2003) P2X1-mediated ERK2 activation amplifies the collagen-induced platelet secretion by enhancing myosin light chain kinase activation. Journal of Biological Chemistry, 278, 4666146667.
  • Turitto, V.T. & Weiss, H.J. (1980) RBC: their dual role in thrombus formation. Science, 207, 541543.
  • Turitto, V.T. & Weiss, H.J. (1998) Mechanical factors affecting hemostasis and thrombosis. Thrombosis Research, 92, S25S31.
  • Turner, N.A., Moake, J.T. & McIntire, L.V. (2001) Blockade of adenosine diphosphate receptor P2Y12 and P2Y1 is required to inhibit platelet aggregation in whole blood under flow. Blood, 98, 33403345.
  • Valles, J., Santos, M.T., Aznar, J., Marcus, A.J., Martinez-Sales, V., Portoles, M., Broekman, M.J. & Safier, L.B. (1991) Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment. Blood, 78, 154162.
  • Valles, J., Santos, T., Aznar, J., Osa, A., Lago, A., Cosin, J., Sanchez, E., Broekman, M.J. & Marcus, A.J. (1998) Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality. The effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of erythrocytes on platelet reactivity. Circulation, 97, 350355.
  • Varon, D., Dardik, R., Shenkman, S., Kotev-Emeth, S., Farzame, N., Tamarin, I. & Savion, N. (1997) A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions. Thrombosis Research, 85, 283294.
  • Weiss, H.J., Lages, B., Hoffmann, T. & Turitto, V.T. (1996) Correction of the platelet adhesion defect in delta-storage pool deficiency at elevated hematocrit – possible role of adenosine diphosphate. Blood, 87, 42144222.
  • van Willigen, G., Hers, I., Gorter, G., Akkerman, J.W.N. (1996) Exposure of ligand-binding sites on platelet integrin αIIb/β3 by phosphorylation of the β3 subunit. Biochemical Journal, 314, 769779.